Skip to main content
. Author manuscript; available in PMC: 2013 Nov 7.
Published in final edited form as: Neuropharmacology. 2010 Sep 17;60(0):10.1016/j.neuropharm.2010.09.011. doi: 10.1016/j.neuropharm.2010.09.011

Figure 5. Effect of Zero Minute Pretreatment of PG01042 on the Temporal Expression of SKF 81297-Dependent AIMs in Lesioned Rats.

Figure 5

Unilaterally lesioned rats were injected (i.p.) with PG01042 (●, 10 mg/kg) followed immediately with a constant dose of SKF 81297 (0.05 mg/kg, s.c.). The percent of the mean total AIMs score ± S.E.M. (n = 12) relative to vehicle control (○) as a function of the dose of PG01042 is shown. The mean reduction ± S.E.M. for the normalized total AIMs values using PG01042 was 10 mg/kg, 8.0 ± 6.8% reduction but significance was not achieved (F(1,22) = 0.72, p = 0.40).